[HTML][HTML] Engineered smart materials for RNA based molecular therapy to treat Glioblastoma

RR Singh, I Mondal, T Janjua, A Popat… - Bioactive Materials, 2024 - Elsevier
Glioblastoma (GBM) is an aggressive malignancy of the central nervous system (CNS) that
remains incurable despite the multitude of improvements in cancer therapeutics. The …

[HTML][HTML] Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review

BL Sailo, L Liu, S Chauhan, S Girisa, M Hegde, L Liang… - Cancers, 2024 - mdpi.com
Simple Summary Recent oncological research highlights the promising role of naturally
derived compounds in cancer prevention and treatment. Sulforaphane (SFN), a …

Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 'cytokine storm'

J Gasparello, G Marzaro, C Papi… - International …, 2023 - spandidos-publications.com
Since its spread at the beginning of 2020, the coronavirus disease 2019 (COVID‑19)
pandemic represents one of the major health problems. Despite the approval, testing, and …

Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy

S Kumari, R Gupta, RK Ambasta, P Kumar - Biochimica et Biophysica Acta …, 2023 - Elsevier
Glioblastoma multiforme (GBM) is an aggressive brain cancer showing poor prognosis.
Currently, treatment methods of GBM are limited with adverse outcomes and low survival …

[HTML][HTML] Peptide nucleic acid conjugates and their antimicrobial applications—a mini-review

U Tsylents, I Siekierska, J Trylska - European Biophysics Journal, 2023 - Springer
Peptide nucleic acid (PNA) is a nucleic acid mimic with high specificity and binding affinity to
natural DNA or RNA, as well as resistance to enzymatic degradation. PNA sequences can …

[HTML][HTML] A comprehensive review on function of miR-15b-5p in malignant and non-malignant disorders

S Ghafouri-Fard, T Khoshbakht, BM Hussen… - Frontiers in …, 2022 - frontiersin.org
miR-15b-5p is encoded by MIR15B gene. This gene is located on cytogenetic band 3q25.
33. This miRNA participates in the pathogenesis of several cancers as well as non …

[HTML][HTML] MicroRNAs miR-584-5p and miR-425-3p are up-regulated in plasma of colorectal cancer (CRC) patients: Targeting with inhibitor peptide nucleic acids is …

J Gasparello, C Papi, M Zurlo, L Gambari, A Manicardi… - Cancers, 2022 - mdpi.com
Simple Summary Starting from a list of nine miRNAs found to be dysregulated in the
bloodstream of early-stage colon cancer (CRC) patients, the biological effects of the …

[HTML][HTML] Modulation of AKT pathway-targeting miRNAs for cancer cell treatment with natural products

JP Shiau, YT Chuang, CY Yen, FR Chang… - International journal of …, 2023 - mdpi.com
Many miRNAs are known to target the AKT serine-threonine kinase (AKT) pathway, which is
critical for the regulation of several cell functions in cancer cell development. Many natural …

[HTML][HTML] Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221 …

C Tupini, M Zurlo, J Gasparello, I Lodi, A Finotti… - Pharmaceutics, 2023 - mdpi.com
Combined treatments employing lower concentrations of different drugs are used and
studied to develop new and more effective anticancer therapeutic approaches. The …

[HTML][HTML] Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′, 4′, 5 …

M Zurlo, R Romagnoli, P Oliva, J Gasparello… - International Journal of …, 2022 - mdpi.com
(1) Background: In the development of new and more effective anticancer approaches,
combined treatments appear of great interest. Combination therapy could be of importance …